Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for the first quarter of 2024.
- Net revenue was $982 million in the first quarter, which is down 4% as reported, and 6% in constant currency from Q1 2023
- Overall organic net revenue decreased by 8% year-over-year during the three-month period
- The company reported a net loss of $715 million for the September quarter, including non-cash goodwill impairment charges of $700 million
- On a per-share basis, Q1 loss was $3.94, vs. breakeven in the year-ago quarter
- Q1 adjusted net loss was $19 million or $0.10 per share, compared to adjusted profit of $61 million or $0.34 per share last year
- Adjusted EBITDA came in at $115 million, down 38% as reported, and 39% in constant currency, compared to last year
- For fiscal 2024, the company expects net revenue to be in the range of $4.30 billion to $4.50 billion
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
What to look for when CVS Health (CVS) reports Q3 earnings
Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain
eBay (EBAY): A few factors that helped drive growth in Q3 2024
Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to
